KLC1 and myeloid sarcoma: In a cohort of 102 RRMS patients and 207 neuroimaging alteration-free controls, the rs8702 single nucleotide polymorphism (SNP) in intron 13 of the kinesin light chain 1 (KLC1) gene was implicated in MS susceptibility, with CC carriers being significantly protected from developing the disease (p < 0.05) [143].